IntoCell, Inc.
Develops platform technologies for Antibody-Drug Conjugates (ADCs) for oncology.
287840 | KO
Overview
Corporate Details
- ISIN(s):
- KR7287840003
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 대덕구 신일동로 101, 대전광역시
- Website:
- https://intocell.com/
Description
IntoCell, Inc. is a biotechnology company specializing in the research and development of platform technologies for Antibody-Drug Conjugates (ADCs). The company's core focus is on creating novel biopharmaceuticals, primarily for oncology applications. IntoCell develops proprietary technologies, including its OHPAS™ linker and Payload Modification Technology (PMT™), which are designed to improve the stability, efficacy, and safety of ADC therapeutics. The company advances its own drug pipeline and also collaborates with other pharmaceutical companies through technology transfer and partnership agreements to commercialize its ADC platforms.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-29 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인) (ITC6146RO의 한국 MFDS 임상1상 임상시험계획을 미국 FDA 승…
|
Korean | HTML • 13.5 KB | ||
| 2025-12-24 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 24.6 KB | ||
| 2025-08-29 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청) (ITC6146RO의 한국 MFDS 제1상 임상시험계획 승인신청)
|
Korean | HTML • 8.8 KB | ||
| 2025-08-14 00:00 |
반기보고서 (2025.06)
|
Korean | HTML • 758.7 KB | ||
| 2025-07-16 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 25.3 KB | ||
| 2025-07-09 00:00 |
투자판단관련주요경영사항 (ADC 플랫폼 기술에 대한 실시권 계약 해지)
|
Korean | HTML • 6.6 KB | ||
| 2025-07-07 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | HTML • 146.8 KB | ||
| 2025-06-23 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | HTML • 63.6 KB | ||
| 2025-05-30 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | HTML • 73.6 KB | ||
| 2025-05-29 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | HTML • 185.8 KB | ||
| 2025-05-29 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | HTML • 65.6 KB | ||
| 2025-05-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 24.2 KB | ||
| 2025-05-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 24.1 KB | ||
| 2025-05-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 24.1 KB | ||
| 2025-05-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 24.1 KB |
Automate Your Workflow. Get a real-time feed of all IntoCell, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IntoCell, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IntoCell, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
